CD274 and neoplasm: In an orthotopic in vivo model of murine GBM (GL261 cell line), 24 h after injection at different locations in the brain, the nanoparticles functionalized with the anti-PD-L1 antibody encapsulating dinaciclib were retained in the tumor and more particularly, co-located with TAMCs.